ANIXA BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
ANIXA BIOSCIENCES, INC. (ANIX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $437.26 thousand for the 9-month period ending 2017-07-31, per its 10-Q filed 2017-09-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2017-09-08
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-07-31 was $276.00K, a 1365.89% increase year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-04-30 was -$39.92K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2017-01-31 was $201.19K, a 69.31% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-10-31 was -$62.87K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $87.99K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was -$868.66K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was -$27.04K, a 104.22% decline from fiscal 2013.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $641.33K, a 267.17% increase from fiscal 2012.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2017-07-31 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $236.07K derived: sum of 2 quarters · filed 2017-09-08 | $437.26K 10-Q · filed 2017-09-08 | $374.40K derived: sum of 4 quarters · filed 2017-09-08 |
| 2017-04-30 | -$39.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $161.27K 10-Q · filed 2017-05-26 | $98.40K derived: sum of 3 quarters · filed 2017-05-26 | $117.23K derived: sum of 4 quarters · filed 2017-09-08 |
| 2017-01-31 | $201.19K 10-Q · filed 2017-03-16 | $138.32K derived: sum of 2 quarters · filed 2017-03-16 | $157.15K derived: sum of 3 quarters · filed 2017-09-08 | -$366.27K derived: sum of 4 quarters · filed 2017-09-08 |
| 2016-10-31 | -$62.87K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | -$44.04K derived: sum of 2 quarters · filed 2017-09-08 | -$567.46K derived: sum of 3 quarters · filed 2017-09-08 | $87.99K 10-K · filed 2016-12-08 |
| 2016-07-31 | $18.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$504.59K derived: sum of 2 quarters · filed 2017-09-08 | $150.86K 10-Q · filed 2017-09-08 | $95.50K derived: sum of 4 quarters · filed 2017-09-08 |
| 2016-04-30 | -$523.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $132.03K 10-Q · filed 2017-05-26 | $76.67K derived: sum of 3 quarters · filed 2017-05-26 | $67.36K derived: sum of 4 quarters · filed 2017-05-26 |
| 2016-01-31 | $655.45K 10-Q · filed 2017-03-16 | $600.09K derived: sum of 2 quarters · filed 2017-03-16 | $590.78K derived: sum of 3 quarters · filed 2017-03-16 | -$365.43K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-10-31 | -$55.36K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | -$64.67K derived: sum of 2 quarters · filed 2016-12-08 | -$1.02M derived: sum of 3 quarters · filed 2016-12-08 | -$868.66K 10-K · filed 2016-12-08 |
| 2015-07-31 | -$9.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | -$965.52K derived: sum of 2 quarters · filed 2016-08-19 | -$813.30K 10-Q · filed 2016-08-19 | -$868.45K derived: sum of 4 quarters · filed 2016-08-19 |
| 2015-04-30 | -$956.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | -$803.99K 10-Q · filed 2016-05-20 | -$859.13K derived: sum of 3 quarters · filed 2016-05-20 | -$816.28K derived: sum of 4 quarters · filed 2016-05-20 |
| 2015-01-31 | $152.22K 10-Q · filed 2016-02-19 | $97.07K derived: sum of 2 quarters · filed 2016-02-19 | $139.92K derived: sum of 3 quarters · filed 2016-02-19 | $185.22K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-10-31 | -$55.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$12.29K derived: sum of 2 quarters · filed 2015-12-23 | $33.00K derived: sum of 3 quarters · filed 2015-12-23 | -$27.04K 10-K · filed 2015-12-23 |
| 2014-07-31 | $42.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $88.15K derived: sum of 2 quarters · filed 2015-08-18 | $28.10K 10-Q · filed 2015-08-18 | $97.25K derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-04-30 | $45.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | -$14.75K 10-Q · filed 2015-05-22 | $54.40K derived: sum of 3 quarters · filed 2015-05-22 | $117.72K derived: sum of 4 quarters · filed 2015-05-22 |
| 2014-01-31 | -$60.05K 10-Q · filed 2015-03-09 | $9.11K derived: sum of 2 quarters · filed 2015-03-09 | $72.43K derived: sum of 3 quarters · filed 2015-03-09 | $145.14K derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-10-31 | $69.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $132.47K derived: sum of 2 quarters · filed 2015-01-29 | $205.19K derived: sum of 3 quarters · filed 2015-01-29 | $641.33K 10-K · filed 2015-01-29 |
| 2013-07-31 | $63.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $136.04K derived: sum of 2 quarters · filed 2014-09-15 | $572.18K 10-Q · filed 2014-09-15 | $614.59K derived: sum of 4 quarters · filed 2014-09-15 |
| 2013-04-30 | $72.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $508.86K 10-Q · filed 2014-06-16 | $551.27K derived: sum of 3 quarters · filed 2014-06-16 | $445.27K derived: sum of 4 quarters · filed 2014-06-16 |
| 2013-01-31 | $436.14K 10-Q · filed 2014-03-17 | $478.55K derived: sum of 2 quarters · filed 2014-03-17 | $372.56K derived: sum of 3 quarters · filed 2014-03-17 | $460.58K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $42.41K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | -$63.58K derived: sum of 2 quarters · filed 2014-01-17 | $24.44K derived: sum of 3 quarters · filed 2014-01-17 | $174.67K 10-K/A · filed 2014-01-17 |
| 2012-07-31 | -$105.99K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | -$17.97K derived: sum of 2 quarters · filed 2013-09-20 | $132.26K 10-Q/A · filed 2013-09-20 | $239.29K derived: sum of 4 quarters · filed 2013-09-20 |
| 2012-04-30 | $88.03K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $238.25K 10-Q/A · filed 2013-06-19 | $345.28K derived: sum of 3 quarters · filed 2013-06-19 | $146.73K derived: sum of 4 quarters · filed 2013-06-19 |
| 2012-01-31 | $150.23K 10-Q/A · filed 2013-03-25 | $257.25K derived: sum of 2 quarters · filed 2013-03-25 | $58.71K derived: sum of 3 quarters · filed 2013-03-25 | $28.08K derived: sum of 4 quarters · filed 2013-03-25 |
| 2011-10-31 | $107.03K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$91.52K derived: sum of 2 quarters · filed 2013-01-29 | -$122.15K derived: sum of 3 quarters · filed 2013-01-29 | $10.35K 10-K · filed 2013-01-29 |
| 2011-07-31 | -$198.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | -$229.17K derived: sum of 2 quarters · filed 2012-09-14 | -$96.68K 10-Q · filed 2012-09-14 | -$139.03K derived: sum of 4 quarters · filed 2012-09-14 |
| 2011-04-30 | -$30.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $101.87K 10-Q · filed 2012-06-14 | $59.51K derived: sum of 3 quarters · filed 2012-06-14 | |
| 2011-01-31 | $132.49K 10-Q · filed 2012-03-16 | $90.14K derived: sum of 2 quarters · filed 2012-03-16 | ||
| 2010-10-31 | -$42.36K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $53.95K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $96.30K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |